CDC's Decision on Gardasil HPV Vaccine
The Centers for Disease Control and Prevention (CDC) has decided to keep the existing dosing schedule for Merck & Co's (MRK, Financial) Gardasil HPV vaccine unchanged, opting for the two to three-dose regimen. This decision is in line with Merck's recent advocacy efforts to preserve the FDA-approved guidelines, ensuring the continuity of their current vaccine strategy.
https://www.gurufocus.com/news/2935010/merck-mrk-gains-as-cdc-agenda-omits-gardasil-dose-changes
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.